share_log

石藥集團:截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

香港交易所 ·  Mar 1 03:47
Summary by Moomoo AI
石藥集團有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋2024年2月份的股份變動情況。報告顯示,公司在2月份並無法定或註冊股本的變動。然而,根據2015年購股權計劃,公司於2月底的股份期權結存為50,000,000股,並且本月內沒有新股份因行使股份期權而發行,因此行使期權所得資金總額為0港幣。該計劃於2015年12月9日生效,並獲股東大會通過。報告由董事翟健文呈交,並未涉及其他類型的證券變動,如承諾發行權證、可換股票據或其他協議安排。
石藥集團有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋2024年2月份的股份變動情況。報告顯示,公司在2月份並無法定或註冊股本的變動。然而,根據2015年購股權計劃,公司於2月底的股份期權結存為50,000,000股,並且本月內沒有新股份因行使股份期權而發行,因此行使期權所得資金總額為0港幣。該計劃於2015年12月9日生效,並獲股東大會通過。報告由董事翟健文呈交,並未涉及其他類型的證券變動,如承諾發行權證、可換股票據或其他協議安排。
Petrochemical Group Limited filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited, covering the stock changes for February 2024. The report shows that the company was not able to fix or register changes in share capital in February. However, under the Share Option Scheme 2015, the Company had a share option deposit of 50,000,000 shares at the end of February and no new shares were issued during the month as a result of the exercise of the share option, so the total amount of proceeds from the exercise of the option was HK$0. The Plan became effective on 9 December 2015 and was approved by the General Meeting. The report was submitted by Director Chai Jianwen and did not involve changes in other types of securities, such as undertaking to issue warrants, convertible stock notes or other contractual arrangements.
Petrochemical Group Limited filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited, covering the stock changes for February 2024. The report shows that the company was not able to fix or register changes in share capital in February. However, under the Share Option Scheme 2015, the Company had a share option deposit of 50,000,000 shares at the end of February and no new shares were issued during the month as a result of the exercise of the share option, so the total amount of proceeds from the exercise of the option was HK$0. The Plan became effective on 9 December 2015 and was approved by the General Meeting. The report was submitted by Director Chai Jianwen and did not involve changes in other types of securities, such as undertaking to issue warrants, convertible stock notes or other contractual arrangements.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more